PharMerica CORP — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/95371fe4-1246-4fe3-aa37-26bfe64a39e3/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $38.4M | 2016-01-01 – 2016-12-31 | evidence 0001388195-17-000004 |
| FY 2015 | $53.8M | 2015-01-01 – 2015-12-31 | evidence 0001388195-16-000017 |
| FY 2014 | $30.4M | 2014-01-01 – 2014-12-31 | evidence 0001140361-15-009509 |
| FY 2013 | $55.8M | 2013-01-01 – 2013-12-31 | evidence 0001140361-14-010064 |
| FY 2012 | $48.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-043434 |
| FY 2011 | $47.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-049228 |
| FY 2010 | $35.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-049228 |
| FY 2009 | $70.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-049228 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).